Nausea no more? D.C. biotech gets motion sickness drug to next stage.


The company’s latest experimental drug was tested on more than 100 patients with motion sickness traveling on the Pacific Ocean.

Previous Blue Cross denied Kelly Doran a scan during his recovery from lung cancer. So he switched his 250 employees to HealthPartners
Next Foreign homebuyers backing away from U.S. market